Milton J. Wallace, Director at Catalyst Pharmaceutical Partners, Inc. (CPRX), bought 44,900 shares at $0.73 ($32K) on 2009-11-17, disclosed to the SEC on 2009-11-19.
Open-market purchase of $32k CPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.73 | 19,846 | $14K | 46.0% |
| 2 | $0.68 | 25,054 | $17K | 54.0% |
| Total | $0.70 avg | 44,900 | $32K | 100% |
| Filing → |
| CPRX | BUY | 2012-05-29 | $100K | — | Filing → |
| IPII | BUY | 2011-08-18 | $1K | — | Filing → |
| IPII | BUY | 2011-06-02 | $340 | — | Filing → |